(Q34675920)

3 August 2017

title

Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity (English)

1 reference

3 August 2017

0 references

Durairaj M Kumar

1

1 reference

3 August 2017

Vikas Patil

2

1 reference

3 August 2017

Bini Ramachandran

3

1 reference

3 August 2017

Murugesan V Nila

4

1 reference

3 August 2017

Kuppamuthu Dharmalingam

5

1 reference

3 August 2017

Kumaravel Somasundaram

6

1 reference

3 August 2017

publication date

14 June 2013

1 reference

3 August 2017

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

issue

14

1 reference

3 August 2017

page(s)

2113-2124

1 reference

Malignant astrocytic glioma: genetics, biology, and paths to treatment

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Treatment of brain metastases of malignant melanoma with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Phase I study of temozolomide in relapsed/refractory acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Proteomic Identification of Haptoglobin α2 as a Glioblastoma Serum Biomarker: Implications in Cancer Cell Migration and Tumor Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

IRAK-4-dependent degradation of IRAK-1 is a negative feedback signal for TLR-mediated NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Aminoacyl tRNA synthetases and their connections to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Genotype, enzyme activity, glutathione level, and clinical phenotype in patients with glutathione synthetase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Adult-onset primary open-angle glaucoma caused by mutations in optineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Toll-like receptor signaling pathways--therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Recent patents in Toll-like receptor pathways and relevance to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Differential expression of the CD14/TLR4 complex and inflammatory signaling molecules following i.c.v. administration of LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Characterization of RhoA-mediated chemoresistance in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Stimulation of human Toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

FADD negatively regulates lipopolysaccharide signaling by impairing interleukin-1 receptor-associated kinase 1-MyD88 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

O 6-Methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200261

21 January 2018

Identifiers

DOI

10.1002/PMIC.201200261

1 reference

3 August 2017

1 reference